Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
NKX019 for Systemic Sclerosis
Recruiting1 awardPhase 1
Hackensack, New Jersey
This trial aims to test the safety of a new treatment called NKX019 in patients with Immune-Mediated Diseases like systemic sclerosis, idiopathic inflammatory myopathies, and ANCA-associated vas
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service